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SConclusions: Our results conﬁrm previously reported incidences of 1-2 % of PIE
post-TAVI. Despite early and aggressive therapy TAVI-PIE is associated with a very
high mortality.
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Background: This study sought to evaluate if a new guiding strategy for trans-
catheter aortic valve replacement (TAVR) aimed at minimizing the amount of radi-
ocontrast agent can prevent acute kidney injury (AKI). AKI can increase mortality
after TAVR and the association between AKI and radiocontrast agent volume is well
documented.
Methods: Sixty patients with severe aortic valve stenosis scheduled for TAVR
were randomized to either undergo TAVR guided by angiography (group 1; n ¼ 30)
or by multimodality imaging primarily based on intracardiac echocardiography
(ICE) (Figure) (group 2; n ¼ 30). AKI was deﬁned and staged according to the VARC
criteria.
Results: Contrast volumes were markedly smaller in group 2 (mean D -61.9 ml (95%
CI -70.6 to -53.3)). Serum creatinine levels were lower and eGFR was higher in group
2 on days three and 30 (p < 0.05). AKI occurred in 6 (20%) group 2 and in 11 (37%)
group 1 patients (OR ¼ 0.43 (95% CI 0.14 to 1.38)) with a trend toward a lower risk
in group 2 (p < 0.05). The risk of severe AKI was lower (OR ¼ 0.47 (95% CI 0.36
to 0.62)), the in-hospital stay was shorter (mean D -3.7 days (95% CI -5.7 to -1.6)),
and the complication rate was not higher (OR ¼ 0.46 (95% CI 0.10 to 2.05)) in
group 2.
Conclusions: An ICE-based guiding technique reduces severity and probably rate of
AKI in TAVR. This is due to reduction of the amount of radiocontrast medium. The
approach does not increase procedural risks.TCT-111
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Background: Transcatheter aortic valve (TAV) replacement has emerged as the
treatment of choice in non-operable patients with severe symptomatic aortic stenosis
and an effective alternative to surgical valve replacement in high surgical risk
patients. Proper evaluation of transcatheter valve long-term durability is critical for
potential expansion of this technology to lower risk patients. The objective of this
study was to develop the ﬁrst fully coupled ﬂuid-structure interaction (FSI) simulation
of a transcatheter valve under physiologic condition to determine strain and stress
distribution on the leaﬂets critical to assessing valve integrity and long-term
durability.
Methods: TAV leaﬂet geometry used in this study was obtained based on the 23mm
Edwards SAPIEN XT valve. FSI simulation was performed using ANSYS Fluent and
Mechanical co-simulation coupling in ANSYS Workbench. The blood ﬂow was
modeled with as a Newtonian Fluid using the k-ε turbulence model which is capable
of modeling laminar, transitional and fully-turbulent ﬂow. The TAV leaﬂets were
modeled with the Mooney-Rivlin hyper-elastic material model. A custom-built pulse
duplicator was utilized to validate FSI simulation. Flow ﬁeld was validated using
phase-locked particle image velocimetry (PIV) measurements. Furthermore, leaﬂet
motion and deformation was measured by tracking the displacements of small markers
placed in the central region of TAV leaﬂets.B36 JACC Vol 62/18/Suppl B j OctoResults: FSI results compared favorably to the measured experimental data. Quali-
tatively the velocity ﬂow ﬁeld from the simulation compared similarly to what was
observed in the PIV measurements with a maximum velocity of 0.9 m/s. The pressure
gradient across the valve was 9.1 mm-Hg which was comparable to the experimental
data. Furthermore, a good correlation between the experimental and simulation results
in terms of leaﬂet motion and deformation was achieved.
Conclusions: The developed fully-coupled FSI simulation allows for a quantitative
analysis of strain and stress distribution on TAV leaﬂets necessary to assess long-term
durability of TAVs. The computational model could be an enabling tool for TAV
design improvements.TAVR - Outcomes
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Background: Quality of life is lower after transapical transcatheter aortic valve
replacement (TA-TAVR) as compared to surgical aortic valve replacement (SAVR)
and transfemoral TAVR (TF-TAVR). We investigated whether changes in left
ventricular ejection fraction (LVEF) might explain these differences.
Methods: Echocardiography-derived LVEF and other variables were compared at
baseline, 1 month and 6 months after TF-TAVR, TA-TAVR and SAVR in patients
enrolled in the PARTNER (Placement of Aortic Transcatheter Valves) Trial (Cohort A
and B) and the non-randomized continued access registry.
Results: In total, 1,021 patients underwent TF-TAVR, 1037TA-TAVRand 305 SAVR.
The mean LVEF in the TF-TAVR and SAVR groups increased signiﬁcantly from
baseline to 30 days by 3% (5213% to 5512%, p<0.001 for TAVR and 5312% to
5611%, p¼0.03 for SAVR). The mean LVEF in the TA-TAVR group did not change
(53 12% to 53 12%, p¼0.18). In patients with a baseline LVEF>45%, there was
a signiﬁcant 1% decrease in LVEF from baseline to 6 months in the TA-TAVR group
(58.86.3% to 57.87.6%, p<0.001) compared to no change in the TF-TAVR group
(59.4 6.2% to 59.7 7.2%, p¼0.991). In those patients with a baseline LVEF<45%,
there was a signiﬁcantly greater increase in the LVEF in the TF-TAVR group as
compared to the TA-TAVR patients (12 9% vs. 8 11%, p¼0.002). Moderate or
severe paravalvular aortic regurgitation was signiﬁcantly more frequent at 6 months in
the TF-TAVR group as compared to the TA-TAVR group (14.8% vs. 6.9%, p<0.001).
Conclusions: In patients with severe aortic stenosis, there is blunted improvement in
LVEF after TA-TAVR as compared to TF-TAVR or to SAVR. This ﬁnding may have
important implications when considering non-transfemoral approaches for TAVR,
such as a direct transaortic approach.ber 27–November 1, 2013 j TCT Abstracts/ORAL/TAVR - Outcomes
